Detalles de la búsqueda
1.
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
Br J Cancer
; 120(1): 57-62, 2019 01.
Artículo
Inglés
| MEDLINE | ID: mdl-30377342
2.
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report.
BMC Cancer
; 19(1): 410, 2019 Apr 30.
Artículo
Inglés
| MEDLINE | ID: mdl-31039766
3.
Prevalence of Long COVID Symptoms Related to SARS-CoV-2 Strains.
Life (Basel)
; 13(7)2023 Jul 13.
Artículo
Inglés
| MEDLINE | ID: mdl-37511933
4.
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.
Eur J Cancer
; 123: 72-80, 2019 12.
Artículo
Inglés
| MEDLINE | ID: mdl-31671314
5.
Medical treatment of malignant pleural mesothelioma relapses.
J Thorac Dis
; 10(Suppl 2): S333-S341, 2018 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-29507803
6.
The dawn of "immune-revolution" in children: early experiences with checkpoint inhibitors in childhood malignancies.
Cancer Chemother Pharmacol
; 80(6): 1047-1053, 2017 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-29067473
7.
Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report.
Oncol Lett
; 14(5): 5947-5951, 2017 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-29113230
8.
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction.
Mol Med Rep
; 14(3): 2238-42, 2016 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-27430882
Resultados
1 -
8
de 8
1
Próxima >
>>